You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation
  1. Alexandre Pariente
  1. Correspondence to Dr Alexandre Pariente, Unité d'hépatogastroentérologie, Centre Hospitalier, Boulevard Hauterive, Pau 64000, France; alex.pariente{at}free.fr

https://doi.org/10.1136/gutjnl-2013-306530

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Liu et al 1 have to be commended for their recent report concerning the predictive value of hepatitis B virus (HBV) seromarkers clearance for hepatocellular carcinoma (HCC) risk in the REVEAL study. There are, however, some limits and interrogations:

    • The incidence rates of HCC are measured from baseline (as the characteristics of the patients) and not from …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles